Bromfenac 0.09% vs Ketorolac 0.4% for Cyclosporine Induction Phase

Inclusion Criteria: * Must be in general good health * Diagnosis of moderate to severe dry eye syndrome Exclusion Criteria: * Patients who are unlikely to respond to cyclosporine ophthalmic emulsion therapy * Patients who are pregnant or nursing females * Unwilling to discontinue use of contact lenses during the run-in and duration of the study * Presence or history of any systemic or ocular disorder or condition that could possibly interfere with the interpretation of the study results in the study eye * Previous treatment failure on CSA 0.05% (Restasis) * Known hypersensitivity to any component of the study or procedural medications * Participation in any other clinical trial within 30 days prior to screening * Known contraindication to any study medication or any of their components. * Should not be taking any oral anti-histamines, beta blockers or diuretics.